CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
+66.58%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.82B
AUM Growth
+$1.82B
(-3.4%)
Cap. Flow
+$20.8M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
65.19%
Holding
53
New
8
Increased
7
Reduced
11
Closed
5
Top Buys
| 1 |
Praxis Precision Medicines
PRAX
|
$63.4M |
| 2 |
Janux Therapeutics
JANX
|
$56.2M |
| 3 |
DRUG
Bright Minds Biosciences
DRUG
|
$38.2M |
| 4 |
NewAmsterdam Pharma
NAMS
|
$20M |
| 5 |
OKUR
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
|
$15.8M |
Top Sells
| 1 |
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
|
$93M |
| 2 |
Vaxcyte
PCVX
|
$47.1M |
| 3 |
UroGen Pharma
URGN
|
$13.3M |
| 4 |
Biohaven
BHVN
|
$12.9M |
| 5 |
AnaptysBio
ANAB
|
$11.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Neurogene
NGNE
$284M
| – | – |
-107,344
| Closed | -$4.5M |
|
|
SLN
52
Silence Therapeutics
SLN
$237M
| – | – |
-400,000
| Closed | -$7.27M |
|
|
LBPH
53
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| – | – |
-2,790,462
| Closed | -$93M |
|